KR100628586B1 - 3-데속시-비타민 디3 유사 에스테르 - Google Patents
3-데속시-비타민 디3 유사 에스테르 Download PDFInfo
- Publication number
- KR100628586B1 KR100628586B1 KR1020047004110A KR20047004110A KR100628586B1 KR 100628586 B1 KR100628586 B1 KR 100628586B1 KR 1020047004110 A KR1020047004110 A KR 1020047004110A KR 20047004110 A KR20047004110 A KR 20047004110A KR 100628586 B1 KR100628586 B1 KR 100628586B1
- Authority
- KR
- South Korea
- Prior art keywords
- formula
- group
- compound
- alkyl
- hydroxy
- Prior art date
Links
- 0 *O[C@@](CCCC1=CCP(*)(N)O)C1=C Chemical compound *O[C@@](CCCC1=CCP(*)(N)O)C1=C 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32387001P | 2001-09-21 | 2001-09-21 | |
| US32395701P | 2001-09-21 | 2001-09-21 | |
| US60/323,957 | 2001-09-21 | ||
| US60/323,870 | 2001-09-21 | ||
| PCT/EP2002/010233 WO2003027065A1 (en) | 2001-09-21 | 2002-09-12 | 3-desoxy-vitamin d3 analog esters |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20040035853A KR20040035853A (ko) | 2004-04-29 |
| KR100628586B1 true KR100628586B1 (ko) | 2006-09-26 |
Family
ID=26984180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020047004110A KR100628586B1 (ko) | 2001-09-21 | 2002-09-12 | 3-데속시-비타민 디3 유사 에스테르 |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1430026A1 (ru) |
| JP (1) | JP2005503434A (ru) |
| KR (1) | KR100628586B1 (ru) |
| CN (1) | CN1285573C (ru) |
| AU (1) | AU2002338672B2 (ru) |
| BR (1) | BR0212719A (ru) |
| CA (1) | CA2459789A1 (ru) |
| MX (1) | MXPA04002640A (ru) |
| PA (1) | PA8554901A1 (ru) |
| PE (1) | PE20030429A1 (ru) |
| PL (1) | PL370352A1 (ru) |
| RU (1) | RU2296121C2 (ru) |
| UY (1) | UY27448A1 (ru) |
| WO (1) | WO2003027065A1 (ru) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL376148A1 (en) * | 2002-10-23 | 2005-12-27 | Leo Pharma A/S | Vitamin d analogues, compositions comprising said analogues and their use |
| AU2005289664A1 (en) * | 2004-09-24 | 2006-04-06 | Bioxell S.P.A. | 20-cycloalkyl,26,27-alkyl/haloalkyl vitamin D3 compounds and methods of use thereof |
| WO2006051106A1 (en) | 2004-11-12 | 2006-05-18 | Bioxell Spa | Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer |
| CN102124301B (zh) | 2008-08-22 | 2014-04-02 | Nxp股份有限公司 | 基于位置的服务 |
| CN110339205B (zh) * | 2019-08-19 | 2021-08-24 | 山东德信生物科技有限公司 | 富氢水组合物在抑制六价铬诱导的df-1细胞内质网应激及自噬中的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG70010A1 (en) * | 1996-05-23 | 2000-01-25 | Hoffmann La Roche | Fluorinated vitamin d3 analogs |
| DE69814109T2 (de) * | 1997-09-08 | 2004-02-26 | F. Hoffmann-La Roche Ag | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga |
| US6331642B1 (en) * | 1999-07-12 | 2001-12-18 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
-
2002
- 2002-09-12 WO PCT/EP2002/010233 patent/WO2003027065A1/en not_active Application Discontinuation
- 2002-09-12 EP EP02777075A patent/EP1430026A1/en not_active Withdrawn
- 2002-09-12 JP JP2003530656A patent/JP2005503434A/ja active Pending
- 2002-09-12 BR BR0212719-9A patent/BR0212719A/pt not_active IP Right Cessation
- 2002-09-12 CA CA002459789A patent/CA2459789A1/en not_active Abandoned
- 2002-09-12 RU RU2004112217/04A patent/RU2296121C2/ru not_active IP Right Cessation
- 2002-09-12 MX MXPA04002640A patent/MXPA04002640A/es active IP Right Grant
- 2002-09-12 KR KR1020047004110A patent/KR100628586B1/ko not_active IP Right Cessation
- 2002-09-12 PL PL02370352A patent/PL370352A1/xx not_active Application Discontinuation
- 2002-09-12 CN CNB028185285A patent/CN1285573C/zh not_active Expired - Fee Related
- 2002-09-12 AU AU2002338672A patent/AU2002338672B2/en not_active Ceased
- 2002-09-18 PA PA20028554901A patent/PA8554901A1/es unknown
- 2002-09-19 PE PE2002000921A patent/PE20030429A1/es not_active Application Discontinuation
- 2002-09-20 UY UY27448A patent/UY27448A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PA8554901A1 (es) | 2003-12-10 |
| JP2005503434A (ja) | 2005-02-03 |
| BR0212719A (pt) | 2004-08-03 |
| PE20030429A1 (es) | 2003-05-15 |
| RU2296121C2 (ru) | 2007-03-27 |
| CA2459789A1 (en) | 2003-04-03 |
| AU2002338672B2 (en) | 2006-03-09 |
| PL370352A1 (en) | 2005-05-16 |
| MXPA04002640A (es) | 2004-06-07 |
| CN1556795A (zh) | 2004-12-22 |
| UY27448A1 (es) | 2003-03-31 |
| WO2003027065A1 (en) | 2003-04-03 |
| CN1285573C (zh) | 2006-11-22 |
| RU2004112217A (ru) | 2005-07-10 |
| EP1430026A1 (en) | 2004-06-23 |
| KR20040035853A (ko) | 2004-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2326695C2 (ru) | Фармацевтические композиции и способы, включающие комбинации 2-алкилиденовых производных 9-нор-витамина d и бисфосфоната | |
| US5872113A (en) | Fluorinated vitamin D3 analogs | |
| US6492353B1 (en) | 1,3-dihydroxy-20,20-cycloalkyl-vitamin D3analogs | |
| JPH02288829A (ja) | 骨の損耗の予防又は再生不調症の治療又は予防用薬剤 | |
| HRP980224A2 (en) | Vitamin d3 analogs with bis c-20 side chains | |
| KR100628586B1 (ko) | 3-데속시-비타민 디3 유사 에스테르 | |
| KR100351490B1 (ko) | 비스 씨-20 측쇄를 갖는 비타민 디3 유사체 | |
| US6559138B1 (en) | 3-Desoxy-vitamin D3 analog esters | |
| AU733970B2 (en) | Fluorinated vitamin D3 analogs | |
| AU2002338672A1 (en) | 3-desoxy-vitamin D3 analog esters | |
| US7491711B2 (en) | Methods of treatment using 3-desoxy vitamin D3 analogs | |
| RU2223953C2 (ru) | Аналоги витамина D, фармацевтическая композиция, соединения | |
| JP5931845B2 (ja) | ２−メチレン−１９−ノル−２２−メチル−１α，２５−ジヒドロキシビタミンＤ３のジアステレオマー | |
| US9073885B2 (en) | Vitamin D3 lactone derivatives | |
| Manchand et al. | Vitamin D3 analogs with BIS C-20 side chains | |
| JP2007527399A (ja) | ２−メチレン−１９−ノル−２０（Ｓ）−２５−メチル−１α−ヒドロキシカルシフェロール及びその使用 | |
| Manchand et al. | Method of using Vitamin D3 analogs with BIS C-20 side chains | |
| Takenouchi et al. | Vitamin D 3 lactone derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E701 | Decision to grant or registration of patent right | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |